Reference
Igawa S, et al. Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer. Investigational New Drugs 38: 1906-1914, No. 6, Dec 2020. Available from: URL: http://doi.org/10.1007/s10637-020-00948-9
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1837, 30 (2021). https://doi.org/10.1007/s40278-021-88629-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-88629-4